Needham 12th Annual Healthcare Conference, April 30, 2013 highlights
A few of the many talking points from their presentation:
Relaunch of prescription Silenor taking place right now. OTC Silenor targeted for 2016.
Much talk about the launch of Dr. Cocoa . Targeted for back to school season.
Will not be raising capital through stock sales with stock price at this low level.
Will not be making acquisitions with stock when price is this low. If a great opportunity appeared they would sell non-core assets to raise capital for acquisition.
No talk of CFO opening.
If you look up "fast talking salesman" in the dictionary you might see a picture of Cooper C. Collins(not that there's anything wrong with that). The dude talks a mile a minute and he admits to being a sales/business guy not a pharma guy. Says he leaves to pharma part of the business to those that know it.
whopppieeeeeee did he mention when this might be 52 bucks a share , cause thats when I am out .....
dr cocoa ??? LOL urinary tract infection juice called , DR pee pee stinger ......... maybe some loose stool juice .. YUMMIEEEEE way to go PTX . 51 bucks a share , by 2021